Register for free to listen to this article
Listen with Speechify
0:00
1:00
Biocompatibles UK Ltd.
 
 
Biocompatibles has launched a new product in its CelLuminaterange of intracellular delivery systems. The new CelLuminate Vesicle-formingPolymer System (VPS) improves the efficiency of intracellular delivery ofbioactive molecules compared to conventional liposomal systems. It can deliveranything from fluorophores to RNA, DNA and proteins efficiently and withminimal cytotoxic effects. CelLuminate is made from proprietary biomimeticcopolymer and exploits the natural cellular endocytotic pathways. As thesurface chemistry of the vesicles mimics that of cell membranes, the rate andamount of vesicles endocytosed is orders of magnitude higher than conventionalliposomal systems. Being pH-sensitive, the CelLuminate vesicles utilize the pHdrop in the endosome to deliver the desired payload into the cell cytosol.CelLuminate VPS is designed so that researchers can prepare their own vesiclesto encapsulate any bioactive agent, easily and without experience.
 
 
Biocompatibles UK Ltd.
www.celluminate.com
+44 (0)1252 732 671 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue